Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07193524 · ClinicalTrials.gov registry record · NA
Assessment of the Feasibility of Using a Preoperative Surgical Fracture Analysis Tool
A NA study of Tibia Fractures and Trauma (Including Fractures), sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 2
- Study locations
NCT07193524: Recruiting NA study of Tibia Fractures and Trauma (Including Fractures), sponsored by Brigham and Women's Hospital.
NCT07193524 is a NA study of Tibia Fractures and Trauma (Including Fractures) that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07193524, a NA study of Tibia Fractures and Trauma (Including Fractures), is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study aims to evaluate a preoperative fracture analysis tool that uses 3D visualization and biomechanical modeling to assist surgeons in planning screw and plate fixation for complex tibial plateau fractures. By simulating different fixation strategies based on patient-specific CT data, the tool provides insights into construct stability, potentially improving surgical precision and reducing intraoperative uncertainty. The study also investigates the tool's feasibility within current clinical workflows without altering the standard of care.
Primary Outcome
Surgeons will fill out a questionnaire after the surgery to assess the clinical feasibility of the analysis tool.
Conditions Studied
Interventions
- DEVICE 3D Fracture Analysis Tool
Study Locations (2)
Massachusetts
- Massachusetts General Hospital - Boston
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-09-10 |
| Est. Completion | 2028-09 |
| Phase | NA |
What NCT07193524 shows while recruiting
NCT07193524 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with Tibia Fractures appearing as the primary indexed condition, and to 1 intervention - of which 3D Fracture Analysis Tool is the first listed.
NCT07193524 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07193524 about?
NCT07193524 is a clinical study titled "Assessment of the Feasibility of Using a Preoperative Surgical Fracture Analysis Tool". This study aims to evaluate a preoperative fracture analysis tool that uses 3D visualization and biomechanical modeling to assist surgeons in planning screw and plate fixation for complex tibial plateau fractures. By simulating different fixation strategies based on patient-specific CT data, the too...
What is the current status of trial NCT07193524?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-09-10. Estimated completion is 2028-09.
What conditions does trial NCT07193524 study?
This clinical trial studies the following conditions: Tibia Fractures, Trauma (Including Fractures), Surgical Planning.
What interventions are being tested in trial NCT07193524?
The interventions under investigation include: 3D Fracture Analysis Tool (DEVICE).
Who is sponsoring clinical trial NCT07193524?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07193524 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07193524's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI